Skip to content

Prostate Impendance Test Project

Prostate Impendance Test Project (PROS.IT) in Prostate Cancer Diagnosis: a Cross-sectional Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03428087
Acronym
PROSIT
Enrollment
100
Registered
2018-02-09
Start date
2017-07-01
Completion date
2018-06-30
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impedance Test, Prostatic Biopsy, Prostatic Neoplasms, PSA

Brief summary

Impedance-based analysis could provide an adequate response to the need to identify a safe and reliable tool alternative to bioptic diagnosis. Patients who are candidates for prostate biopsy as suffering from urinary symptoms accompanied by clinical suspicions such as high total PSA value and / or presence of prostate nodule and / or evidence of obvious lesion to available imaging methods will be subjected to impedance measurement. Aim of this study is to be able to structure a bivariate analysis of the distribution of impedances detected in patients with neoplasia in order to detect test median reference values.

Interventions

None listed

Sponsors

University of Pisa
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. age\> 45 years 2. up of total PSA values beyond the normal range (\> 4 ng / ml) 3. presence or absence of suspicious prostate nodule

Exclusion criteria

1. previous history of cancer 2. BMI\>30 3. patients with previous diagnosis of PIN HG at prostate core biopsy or in active surveillance

Design outcomes

Primary

MeasureTime frame
Impedance-based analysis based on phase-sensitive sensorsduring rectal examination

Countries

Italy

Contacts

Primary ContactTommaso Di Vico, Resident
urologiapisa@gmail.com3393642655

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026